Business
The company will use the funds to develop AI capabilities and move into weight loss, cardiometabolic care, diabetes, thyroid disorders and cardiovascular disease.
Also, JLK has received its seventh regulatory clearance from Japan for its stroke AI.
The company was sold to an affiliate of New Enterprise Associates and a consortium of investors for $1.465 billion and ceased trading on the NYSE on Oct. 2.
The company's platform predicts how people in a clinical trial will respond to treatment.
The launch comes a day after General Catalyst CEO Hemant Taneja announced the closing of the firm’s $485 million acquisition of Ohio healthcare system Summa Health.
Marx Advisory CEO Ed Marx recommends that providers adopt 'AI concierge' models offering personalized treatment or watch AI-empowered patients bypass them for new self-service solutions that offer quicker access to care.
The funds will be used to expand the company's workforce and accelerate development of its AI-powered patient engagement platform, Assort OS.
The partners will study the effectiveness of SpotitEarly's breath-based test for detecting early-stage breast cancer.
The company will use the funds to scale nationally, broaden partnerships with payers and health systems, and expand into new neurological condition areas.
The company makes upright radiation therapy systems using a fixed beam with slow patient rotation instead of a gantry.